DK1446119T3 - Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse - Google Patents

Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse

Info

Publication number
DK1446119T3
DK1446119T3 DK02765268T DK02765268T DK1446119T3 DK 1446119 T3 DK1446119 T3 DK 1446119T3 DK 02765268 T DK02765268 T DK 02765268T DK 02765268 T DK02765268 T DK 02765268T DK 1446119 T3 DK1446119 T3 DK 1446119T3
Authority
DK
Denmark
Prior art keywords
compositions
common cold
ipratropium
xylometazoline
treatment
Prior art date
Application number
DK02765268T
Other languages
Danish (da)
English (en)
Inventor
Hanne Anette Moesgaard
Karin Lowenstein Christensen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Application granted granted Critical
Publication of DK1446119T3 publication Critical patent/DK1446119T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
DK02765268T 2001-09-18 2002-09-18 Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse DK1446119T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en) 2001-09-18 2002-09-18 Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (1)

Publication Number Publication Date
DK1446119T3 true DK1446119T3 (da) 2006-07-10

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02765268T DK1446119T3 (da) 2001-09-18 2002-09-18 Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse

Country Status (21)

Country Link
US (2) US7652030B2 (de)
EP (2) EP1446119B1 (de)
JP (1) JP4500045B2 (de)
KR (1) KR100810872B1 (de)
CN (1) CN1290502C (de)
AT (1) ATE318601T1 (de)
BR (1) BRPI0212586B8 (de)
CA (1) CA2460140C (de)
DE (1) DE60209511T2 (de)
DK (1) DK1446119T3 (de)
EA (1) EA008165B1 (de)
ES (1) ES2259098T3 (de)
HK (1) HK1067984A1 (de)
HU (1) HU226527B1 (de)
MX (1) MXPA04002500A (de)
NO (1) NO334441B1 (de)
NZ (1) NZ531792A (de)
PL (1) PL208686B1 (de)
PT (1) PT1446119E (de)
SI (1) SI1446119T1 (de)
WO (1) WO2003024433A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
EP1446119B1 (de) * 2001-09-18 2006-03-01 Nycomed Danmark ApS Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
WO2005074983A2 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
EP1830886B1 (de) * 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Verfahren zur stabilisierung eines arzneimittels gegen demenz
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
EP2504052B1 (de) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
EP3139979B1 (de) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Einheit, zerstäuber und verfahren
HUE058904T2 (hu) 2014-05-07 2022-09-28 Boehringer Ingelheim Int Porlasztókészülék
PL3236933T3 (pl) * 2014-12-24 2019-05-31 Jadran Galenski Laboratorij D D Kompozycja do podawania donosowego zawierająca wodę morską jako zaróbkę poprawiającą trwałość
MX2015016549A (es) 2015-12-02 2017-06-01 Cortés Borrego Pablo Combinacion de oximetazolina e ipratropio en aplicacion topica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183640T1 (de) * 1991-11-19 1999-09-15 Univ Virginia Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
RU2126248C1 (ru) 1992-12-09 1999-02-20 Берингер Ингельхейм Фармасьютикалз, Инк. Жидкая фармацевтическая композиция в форме аэрозоля
EP0780127A1 (de) 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
CN1253508A (zh) * 1997-04-30 2000-05-17 沃尼尔－朗伯公司 局部鼻用抗炎组合物
CA2311530C (en) * 1998-01-30 2008-06-10 Novartis Consumer Health S.A. Nasal solutions
PT1087750E (pt) 1998-06-18 2004-02-27 Boehringer Ingelheim Pharma Formulacoes farmaceuticas para aerossois com duas ou mais substancias activas
HUP0201700A3 (en) * 1999-06-22 2003-02-28 Boehringer Ingelheim Int Stable xylometazoline and oxymetazoline solutions, their use for producing pharmaceutical compositions and pharmaceutical compositions containing them
EP1446119B1 (de) * 2001-09-18 2006-03-01 Nycomed Danmark ApS Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

Also Published As

Publication number Publication date
CA2460140A1 (en) 2003-03-27
CN1290502C (zh) 2006-12-20
SI1446119T1 (sl) 2006-08-31
BR0212586B1 (pt) 2013-11-19
HU226527B1 (hu) 2009-03-30
NO334441B1 (no) 2014-03-03
BR0212586A (pt) 2004-10-13
EP1446119B1 (de) 2006-03-01
JP4500045B2 (ja) 2010-07-14
US7652030B2 (en) 2010-01-26
WO2003024433A3 (en) 2004-06-10
EP1446119A2 (de) 2004-08-18
PL370536A1 (en) 2005-05-30
NO20041070L (no) 2004-05-18
KR100810872B1 (ko) 2008-03-06
CA2460140C (en) 2009-09-01
US20100093783A1 (en) 2010-04-15
PL208686B1 (pl) 2011-05-31
HUP0402075A2 (hu) 2005-02-28
EP1661570A3 (de) 2012-10-24
EP1661570A2 (de) 2006-05-31
ES2259098T3 (es) 2006-09-16
DE60209511D1 (de) 2006-04-27
CN1555263A (zh) 2004-12-15
HK1067984A1 (en) 2005-04-22
JP2005505569A (ja) 2005-02-24
EA200400444A1 (ru) 2005-02-24
ATE318601T1 (de) 2006-03-15
US20040248924A1 (en) 2004-12-09
PT1446119E (pt) 2006-07-31
WO2003024433A2 (en) 2003-03-27
HUP0402075A3 (en) 2008-04-28
MXPA04002500A (es) 2004-11-22
EA008165B1 (ru) 2007-04-27
DE60209511T2 (de) 2006-10-05
US8450339B2 (en) 2013-05-28
KR20040049849A (ko) 2004-06-12
BRPI0212586B8 (pt) 2021-05-25
NZ531792A (en) 2006-02-24

Similar Documents

Publication Publication Date Title
DK1446119T3 (da) Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
BR0313176A (pt) Composições de pirazol úteis como inibidores de gsk-3
BR9812361A (pt) Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
SE0101932D0 (sv) Pharmaceutical combinations
RS50814B (sr) Tartaratne soli 5,8,14-triazatetraciklo(10.3.1.02,11.04,9)- heksadeka-2(11),3,5,7,9-pentaena
NO2007010I2 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
SG152257A1 (en) Topical preparation containing ambroxol
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
DK1307189T3 (da) Anvendelse af hydroxyethylrutosider til behandling af forkölelsessymptomer, allergiske rhinitis og infektioner relateret til luftvejene
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
ECSP055844A (es) Nuevos compuestos triciclicos
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
BR0212329A (pt) Métodos para tratar doença pulmonar
WO2005039483A3 (en) Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
SE0002353D0 (sv) New use
NO20030021D0 (no) Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV
WO2003043614A3 (en) Reversible proton pump inhibitors for the treatment of airway disorders
EA200500538A1 (ru) Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы